OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS

Equity Capital Raises

Equity Transaction Chart

Viridian publishes weekly data on equity capital raises in the Cannabis/CBD/Psychedelic industries. This data includes information about the company issuing equity (public/private, state/country location), deal size, deal structure, pricing, share information, deal implied valuation, and warrant information.

Week ended 03/15/2024

Week ended 03/15/2024

This Section is Only Available to Higher Tier Memberships

Please Purchase a Premium or Enterprise membership to see more.

Equity Commentary

Viridian publishes weekly insights on equity capital raises in the Cannabis/CBD/Psychedelic industries. These insights typically highlight the most interesting/meaningful equity transactions of that week, and commentary on market conditions, equity deal structures and investor groups.

Week ended 03/15/2024

  • The Week’s Closed Equity Deals
    • On March 11, 2024, Skye Bioscience (SKYE: OTCQB), a clinical-stage biotech company focused on the discovery, development, and commercialization of drugs that modulate the endocannabinoid system, closed a PIPE transaction selling 4M shares for gross proceeds of $40M.
    • The transaction implied a market cap of $199M and an enterprise value of $181M.
    • Proforma liquidity is strong with a free cash flow adjusted current ratio of 2.85x
    • Proceeds will fund the development of the company’s nimacimab drug for obesity.
    • Investors included Perceptive Advisors, Velan Capital, and Schonfeld Strategic Advisors.

Public vs. Private Raises: 

  • Three of this week’s capital raisers are public companies that trade in Canada on the CSE and the U.S. on OTC.

Equity vs. Debt Cap Raises: 

  • Equity accounted for all of this week’s funds raised.

Week ended 03/15/2024

Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more. 

Weekly Valuation Tracker

Viridian highlights a specific industry sector and provides a deep dive into valuation metrics and comparable company valuations for public companies operating in that sector.  The Weekly Valuation Tracker provides proprietary, actionable valuation data.

This week’s valuation tracker focuses on the 7 U.S. MSOs with market cap over $500M in the Viridian Value Tracker database in gauge the valuation impact of the 2nd earnings that have been released so far, Green Thumb (GTII: CSE), Curaleaf (CURA: CSE), and Trulieve.   

This Chart is Only Available to Higher Tier Memberships

Please Purchase a Premium or Enterprise membership to see more.

Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more. 

This Chart is Only Available to Higher Tier Memberships

Please Purchase a Premium or Enterprise membership to see more.